TRIVARX LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.026 AUD | -.--% |
|
+8.33% | -13.33% |
| Feb. 28 | TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Feb. 09 | TrivarX Signs Collaboration with Northern Michigan University on Sleep Research | MT |
Quotes 5-day view
End-of-day quote Australian S.E.| 2024-04-22 | 2024-04-23 | 2024-04-24 | 2024-04-26 | 2024-04-29 | |
|---|---|---|---|---|---|
| Last | 0.024 $ | 0.025 $ | 0.026 $ | 0.026 $ | 0.026 $ |
| Volume | 550 000 | 414 847 | 66 587 | 2 035 518 | 1 053 956 |
| Change | +∞% | +4.17% | +4.00% | -.--% | -.--% |
| Opening | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 |
| High | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 |
| Low | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 |
Performance
| 1 week | +8.33% | ||
| Current month | -10.34% | ||
| 1 month | -10.34% | ||
| 3 months | +8.33% | ||
| 6 months | +18.18% | ||
| Current year | -13.33% | ||
| 1 year | +30.00% | ||
| 3 years | -83.75% | ||
| 5 years | -92.78% | ||
| 10 years | -99.57% |
Volumes
marketsDaily volume
1 053 956
Avg. Volume 20 sessions
513 947
Avg. Volume 20 sessions AUD
13 362.62
Avg. Volume 20 sessions USD
8 665.13
Record volume 1
5 079 485
Record volume 2
5 034 845
Record volume 3
4 899 451
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (AUD)
8 813 105
Capitalization (USD)
5 714 946
Net sales (AUD)
960 451
Net sales (USD)
622 814
Free-Float
71.74 %
Free-Float capitalization (AUD)
6 314 815
Free-Float capitalization (USD)
4 094 905
Average Daily Capital Traded
0.15%
Highs and lows
1 week
0.02
0.03
1 month
0.020.03
Current year
0.020.04
1 year
0.020.04
3 years
0.020.26
5 years
0.020.64
10 years
0.0210.50
Indicators
Moving average 5 days
0.03
Moving average 20 days
0.03
Moving average 50 days
0.03
Moving average 100 days
0.03
Price spread / (MMA5)
+15.38%
Price spread / (MMA20)
+15.38%
Price spread / (MMA50)
+15.38%
Price spread / (MMA100)
+15.38%
STIM
RSI 9 days
51.23
RSI 14 days
47.68
Sector Comparison - Specialty & Advanced Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | +8.33% | -13.33% | +30.00% | 5.71M | ||
| -0.67% | +0.85% | +3.37% | -8.37% | 69.25B | ||
| +0.70% | +0.45% | +12.55% | -12.25% | 9B | ||
| +1.98% | +4.04% | -12.75% | +26.96% | 4.96B | ||
| +0.55% | +19.62% | +42.38% | +107.47% | 4.47B | ||
| -0.69% | +1.12% | +5.23% | +31.98% | 3.9B | ||
| -1.04% | -6.45% | +20.00% | -6.75% | 2.45B | ||
| +0.34% | +8.96% | -19.05% | -38.76% | 2.41B | ||
| -2.30% | -1.71% | -28.72% | -45.05% | 2.23B | ||
| +2.93% | +3.42% | +11.13% | -18.99% | 2.02B | ||
| -.--% | -.--% | - | - | 1.64B | ||
| +0.55% | +6.00% | -0.18% | -13.40% | 1.23B | ||
| -0.83% | +0.70% | +16.34% | +30.54% | 1.02B | ||
| +3.25% | +18.92% | -20.76% | -24.55% | 1.03B | ||
| -10.90% | -4.05% | -41.53% | -53.53% | 818M | ||
| -0.65% | +3.90% | +32.97% | +44.58% | 846M | ||
| Average | -0.42% | +1.79% | +0.51% | +3.32% | ||
| Weighted average by Cap. | -0.35% | -1.39% | +4.19% | -2.05% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -13.33% | ||
| 2023 | -25.00% | ||
| 2022 | -63.64% | ||
| 2021 | -31.25% | ||
| 2020 | -20.00% | ||
| 2019 | -52.38% | ||
| 2018 | -93.91% | ||
| 2017 | -10.39% | ||
| 2016 | +28.33% | ||
| 2015 | -.--% | ||
| 2014 | -.--% | ||
| 2013 | +200.00% | ||
| 2012 | -75.00% | ||
| 2011 | -60.00% | ||
| 2010 | -74.36% | ||
| 2009 | +160.02% | ||
| 2008 | -63.42% | ||
| 2007 | +105.00% | ||
| 2006 | -9.09% | ||
| 2005 | -71.79% | ||
| 2004 | -14.28% | ||
| 2003 | -3.19% | ||
| 2002 | -41.25% | ||
| 2001 | +3.22% |
- Stock Market
- Equities
- TRI Stock
- Quotes TrivarX Limited
